EM2AI, an AI dental healthcare company based in Singapore, today announced the launch of its dental AI products. This includes the launch of EM2Clinic, an AI-powered patient-centric cloud solution, and its AI x-ray dental condition detection and automated dental charting (ADC) systems.
The series of AI tools are powered by generative AI algorithms that analyses a comprehensive array of patient-specific data, including medical, dental, and social history, demographics, concerns, and investigations.
“Our new dental AI product represents a culmination of years of rigorous research and development, supported by key government agencies such as AI Singapore that have been tasked to promulgate the usage of AI in Singapore. With this revolutionary technology, we are empowering both dentists and patients with the ability to access transparent treatment plans devoid of bias or preference, ensuring full disclosure and transparency in every aspect of dental care,” said Mr Ryan San, CEO of EM2AI.
With a 49%-ownership from Q & M Dental Group, EM2AI has developed and successfully deployed its ADC systems in all Q & M Dental clinics in Singapore. These are integrated into the Q & M app that is now available to the public for download.
Furthermore, EM2AI also announced that its generative AI dental treatment plan (GATP) tool which aims to provide dentists and patients with improved transparency and accuracy in treatment planning, is currently undergoing trials and slated for launch in 2H2024. EM2AI is currently in the early stages of rolling out GATP in selected outlets for testing.
The AI-driven system’s core advantage is said to lie in its ability to minimise and remove perceived or unperceived biases or preferences that a dentist might hold, thus improving the transparency, reliability, consistency, and quality of dental diagnoses and treatments.
“EM2AI’s integration of AI in dentistry addresses patients’ concern about excessive or insufficient treatment recommendations, fostering an ethical dental approach that patients are actively pursuing. AI Singapore is committed to driving Singapore’s journey as an AI-first nation. We want to continue supporting our local enterprises as they innovate with AI integration in their offerings, striving to elevate consumer experiences and make a positive impact on society,” said Mr Laurence Liew, director of AI Innovation, AI Singapore.
Furthermore, EM2AI’s model represents a new business paradigm within the dental industry through its Software as a Service (SaaS) offering. The SaaS platform ensures that dental clinics, regardless of their size, can offer state-of-the-art and personalised treatment plans to their patients, fostering a more inclusive and advanced dental care ecosystem.
Through continuous updates and improvements, EM2AI’s system promises to evolve alongside advancements in AI and dental medicine, ensuring that dentists are always equipped with the most effective tools to serve their patients.
With these launches, EM2AI is also planning to seek investors and strategic partners, both locally and overseas, for the next phase of the company’s growth plans.
Related: New AI tools introduced for Planmeca Romexis
